REILLY FINANCIAL ADVISORS, LLC - BLACKROCK HEALTH SCIENCES TR ownership

BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 59 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
REILLY FINANCIAL ADVISORS, LLC ownership history of BLACKROCK HEALTH SCIENCES TR
ValueSharesWeighting
Q4 2021$30,000
+3.4%
6100.0%0.00%0.0%
Q3 2021$29,000
-3.3%
6100.0%0.00%0.0%
Q2 2021$30,000
+7.1%
6100.0%0.00%0.0%
Q1 2021$28,000
-3.4%
6100.0%0.00%
-33.3%
Q4 2020$29,000
+11.5%
6100.0%0.00%0.0%
Q3 2020$26,000
+4.0%
6100.0%0.00%0.0%
Q2 2020$25,000
+13.6%
6100.0%0.00%0.0%
Q1 2020$22,000
-15.4%
6100.0%0.00%0.0%
Q4 2019$26,000
+13.0%
6100.0%0.00%0.0%
Q3 2019$23,000
-17.9%
610
-14.1%
0.00%
-25.0%
Q2 2019$28,0000.0%7100.0%0.00%0.0%
Q1 2019$28,000
+7.7%
7100.0%0.00%0.0%
Q4 2018$26,000
-13.3%
7100.0%0.00%0.0%
Q3 2018$30,000
+11.1%
7100.0%0.00%0.0%
Q2 2018$27,000
+8.0%
7100.0%0.00%
+33.3%
Q1 2018$25,000
-3.8%
7100.0%0.00%
-25.0%
Q4 2017$26,0000.0%7100.0%0.00%0.0%
Q3 2017$26,0000.0%7100.0%0.00%0.0%
Q2 2017$26,000
+4.0%
7100.0%0.00%0.0%
Q1 2017$25,000
+8.7%
7100.0%0.00%0.0%
Q4 2016$23,000
-25.8%
710
-22.0%
0.00%
-20.0%
Q3 2016$31,000
-3.1%
9100.0%0.01%
-16.7%
Q2 2016$32,0000.0%9100.0%0.01%
+20.0%
Q1 2016$32,000
+14.3%
910
+28.2%
0.01%0.0%
Q4 2015$28,000
+3.7%
7100.0%0.01%0.0%
Q3 2015$27,000
-10.0%
7100.0%0.01%0.0%
Q2 2015$30,000
+25.0%
710
+29.1%
0.01%
+25.0%
Q1 2015$24,0005500.00%
Other shareholders
BLACKROCK HEALTH SCIENCES TR shareholders Q1 2022
NameSharesValueWeighting ↓
Nova R Wealth, Inc. 455,058$19,048,71512.88%
Alterity Financial Group, LLC 12,286$514,3090.75%
Cornerstone Advisory, LLC 85,260$3,568,9680.64%
Owen LaRue, LLC 12,912$557,1560.60%
Semus Wealth Partners LLC 13,170$551,2960.59%
PRIMORIS WEALTH ADVISORS, LLC 7,984$334,1940.41%
CORRADO ADVISORS, LLC 9,285$388,6710.26%
Founders Financial Alliance, LLC 10,612$444,3360.22%
Diversified, LLC 12,870$538,7330.19%
Waterfront Wealth Inc. 7,744$324,1780.11%
View complete list of BLACKROCK HEALTH SCIENCES TR shareholders